Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02285439
Title Phase I/II Study of MEK162 for Children With Ras/Raf Pathway Activated Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Children's Hospital Los Angeles , Dana-Farber Cancer Institute
Indications

Advanced Solid Tumor

Therapies

Binimetinib

Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST